New Paper - Chimeric Antigen Receptor–Modified T Cells in Chronic Lymphoid Leukemia

Speaker

David Binder, Graduate Student, Schreiber Lab

Date

September 14, 2011, 1:00 pm – 2:00 pm

Location

GCIS
W301

Description

CABI-JC New Paper - Chimeric Antigen Receptor–Modified T Cells in Chronic Lymphoid Leukemia

Submitting Unit: Committee on Cancer Biology
Type of Event: Journal Club
Date of Event: Wednesday, September 14 2011
Start Time: 12:00 PM
End Time: 1:00 PM
Building: Gordon Center for Integrative Science, Room W301

Name of Series, Lectureship, Ceremony:
CCB Journal Club

Title of talk or presentation:
New Paper - Chimeric Antigen Receptor–Modified T Cells in Chronic Lymphoid Leukemia

Speaker’s Name and Degrees:
David Binder, Graduate Student, Schreiber Lab

Speaker’s Institutional Affiliation:
UChicago

Description:
COMMITTEE ON CANCER BIOLOGY
JOURNAL CLUB

Wednesday, September 14th , 2011
GCIS W301
12:00pm - 1:00pm

Chimeric Antigen Receptor–Modified
T Cells in Chronic Lymphoid Leukemia

David L. Porter, M.D., Bruce L. Levine, Ph.D., Michael Kalos, Ph.D.,
Adam Bagg, M.D., and Carl H. June, M.D.
N Engl J Med 2011;365:725-33.

Presented By:
David Binder, Graduate Student
Committee on Cancer Biology
Schreiber Laboratory

~ Copies of the paper will be available ~


Contact Name
Biomedical Sciences Cluster

Contact Email
beaudreau@bsd.uchicago.edu

Contact Phone
2-1857

Latest News

Jack Gilbert Heading UChicago Startup that Aims to Predict Behavior of Trillions of Microorganisms

IGSB Faculty member Jack Gilbert co-founded Gusto Global to better understand microorganisms inside humans and harness them to treat disease.

Subscribe to RSS Feed